COUGHLIN TIMOTHY
Related Filers (4)
- NEUROCRINE BIOSCIENCES INC (41)
- FATE THERAPEUTICS INC (12)
- Travere Therapeutics, Inc. (10)
- aTYR PHARMA INC (10)
- Show More ...
Ownership (73)
4
Friday, 5/19/2023
aTYR PHARMA INC: Statement of changes in beneficial ownership of securities
4
Friday, 5/19/2023
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 4/28/2023
aTYR PHARMA INC: Statement of changes in beneficial ownership of securities
4
Monday, 6/13/2022
FATE THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Monday, 6/6/2022
FATE THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 5/12/2022
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/28/2022
aTYR PHARMA INC: Statement of changes in beneficial ownership of securities
4
Friday, 6/4/2021
FATE THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/18/2021
Travere Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/29/2021
aTYR PHARMA INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/19/2020
Retrophin, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/8/2020
aTYR PHARMA INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/5/2020
FATE THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Friday, 5/10/2019
Retrophin, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/10/2019
aTYR PHARMA INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/7/2019
FATE THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 5/17/2018
aTYR PHARMA INC: Statement of changes in beneficial ownership of securities
4
Friday, 5/11/2018
Retrophin, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/4/2018
FATE THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 5/18/2017
Retrophin, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/11/2017
aTYR PHARMA INC: Statement of changes in beneficial ownership of securities
4
Thursday, 5/4/2017
FATE THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
3
Monday, 4/10/2017
aTYR PHARMA INC: Initial statement of beneficial ownership of securities
4
Monday, 4/10/2017
aTYR PHARMA INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/8/2017
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Monday, 2/6/2017
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/18/2017
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Thursday, 1/12/2017
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Monday, 11/28/2016
FATE THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 5/19/2016
Retrophin, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/13/2016
FATE THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/9/2016
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Thursday, 2/4/2016
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Thursday, 1/21/2016
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/13/2016
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Monday, 10/19/2015
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/21/2015
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/14/2015
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/10/2015
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Friday, 5/15/2015
FATE THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
3
Thursday, 4/2/2015
Retrophin, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 4/2/2015
Retrophin, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/24/2015
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Thursday, 2/5/2015
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/21/2015
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/13/2015
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Friday, 1/9/2015
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Friday, 12/19/2014
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Friday, 12/12/2014
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/2/2014
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Monday, 11/3/2014
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Thursday, 10/30/2014
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Monday, 6/9/2014
FATE THERAPEUTICS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/21/2014
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Monday, 1/13/2014
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/8/2014
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
3
Monday, 9/30/2013
FATE THERAPEUTICS INC: Initial statement of beneficial ownership of securities
4
Thursday, 8/22/2013
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/7/2013
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Monday, 1/14/2013
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/17/2012
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Monday, 8/29/2011
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/2/2011
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/12/2010
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/3/2010
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/13/2010
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/1/2009
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/1/2009
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Thursday, 1/15/2009
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Friday, 2/29/2008
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Thursday, 2/14/2008
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/16/2007
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
3
Wednesday, 9/20/2006
NEUROCRINE BIOSCIENCES INC: Initial statement of beneficial ownership of securities